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Glioblastoma (GBM) is the most common and aggressive primary brain tumor, and is
notable for spreading so effectively through the brain parenchyma to make complete
surgical resection virtually impossible, and prospect of life dismal. Several ion channels
have been involved in GBM migration and invasion, due to their critical role in supporting
volume changes and Ca2+ influx occuring during the process. The large-conductance,
Ca2+-activated K (BK) channels, markedly overexpressed in biopsies of patients with
GBMs and in GBM cell lines, have attracted much interest and have been suggested
to play a central role in cell migration and invasion as candidate channels for providing
the ion efflux and consequent water extrusion that allow cell shrinkage during migration.
Available experimental data on the role of BK channel in migration and invasion are
not consistent though. While BK channels block typically resulted in inhibition of cell
migration or in no effect, their activation would either enhance or inhibit the process. This
short review reexamines the relevant available data on the topic, and presents a unifying
paradigm capable of reconciling present discrepancies. According to this paradigm, BK
channels would not contribute to migration under conditions where the [Ca2+]i is too low
for their activation. They will instead positively contribute to migration for intermediate
[Ca2+]i, insufficient as such to activate BK channels, but capable of predisposing them to
cyclic activation following oscillatory [Ca2+]i increases. Finally, steadily active BK channels
because of prolonged high [Ca2+]i would inhibit migration as their steady activity would
be unsuitable to match the cyclic cell volume changes needed for proper cell migration.
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Introduction
Glioblastoma (GBM) is the most common and aggressive primary brain tumor, and is
remarkable for its high migratory and invasive potential (Holland, 2001; Nakada et al.,
2007; Sforna et al., 2015). Unlike other tumors, GBMs do not disseminate through the
vasculature to form metastasis in other organs. Yet they are not less lethal; they spread in
fact so effectively through the brain parenchyma that at the time of diagnosis cells have
already largely infiltrated the surrounding tissues making complete eradication of the tumor
virtually impossible and prospect of life dismal (mean survival from diagnosis, 12–18 months).
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Cell migration and invasion into the healthy brain parenchyma is
thus a key process we need to understand thoroughly if we want
to have a chance to successfully confront this fatal tumor.
The basics of the migration process can be approximated by
cells moving in a culture dish on a flat two-dimensional (2D)
surface. Cell migration in 2D encounters no steric hindrance
or frictional forces arising from the surrounding environment,
and can be modeled as a strictly controlled cyclic sequence of
events consisting of initial protrusion of the cell leading edge,
its adhesion to the substrate, actin cytoskeletal rearrangements,
cell contraction and detachment of adhesion sites at the rear end
(Li et al., 2005). By contrast, invasion of tumor cells into brain
parenchyma can be better approximated by cells moving inside a
3D gel matrix, where invading cells have to overcome forces that
arise from the steric hindrance of the matrix network, provided
that the pores through which the cell moves are smaller than
the cell itself. Cells try to overcome these obstacles by changing
shape and volume to fit through the extracellular matrix (ECM)
trabecular structure, and trying to digest and deform the ECM to
widen the pores for their passage (Cuddapah and Sontheimer,
2011; Vehlow and Cordes, 2013). Regardless of the type of
migration, Ca2+ signals play a major regulatory role, as they
target most of the proteins involved (Wei et al., 2012). Notably,
repetitive Ca2+ oscillations due to the cyclic release of Ca2+ from
the intracellular stores have been implicated in the migration of
GBM cells (Bordey et al., 2000; Rondé et al., 2000; Ishiuchi et al.,
2002; Lyons et al., 2007; Catacuzzeno et al., 2011). These cyclic
Ca2+ waves induced by serum or more specific extracellular
agonists are essential for the migratory process, as they promote
the cell rear detachment from the substrate and the volume
changes accompanying cell rear retraction (Giannone et al., 2002;
Watkins and Sontheimer, 2011).
GBM cell invasion critically depends on ion channels,
determinant for dynamic volume regulation and intracellular
Ca2+ signals. As for cell volume regulation, the prevailing view
considers the concerted opening of K and Cl channels with
the resulting efflux of KCl and osmotic water as the critical
step underlying cell shrinkage during GBM cell migration and
infiltration (Catacuzzeno et al., 2014; Turner and Sontheimer,
2014). The Cl− efflux involved in this process has been shown
to be mainly sustained by the ClC-3 type Cl channel. As for
the K+ contribution, two Ca2+-activated K (KCa) channels
have the properties for playing major roles in the process—the
large (BK, KCa1.1) and intermediate (IK, KCa3.1) conductance
Ca2+-activated K channels. Not only these channels concur
in controlling the cell volume; by modulating the membrane
potential they affect the driving force for Ca2+ influx and thus
exert a secondary control on cell migration through regulation
of [Ca2+]i signals. The relevance of IK channels to GBM
cell migration is now largely established (Fioretti et al., 2006;
Sciaccaluga et al., 2010; Catacuzzeno et al., 2011, 2012a; Ruggieri
et al., 2012; D’Alessandro et al., 2013). The contribution of BK
channels to migration is instead less clear. Available data are
not always consistent with a well-defined role of this channel
type in cell migration/invasion. While BK channels inhibition
typically resulted in restraint of cell migration, and in some
instances was ineffective, their activation would either enhance
or inhibit migration. In other words, evidence supporting their
participation in GBM cell migration/invasion is still uncertain,
or conflicting at times. This review will focus on and examine the
role of BK channels in migration and invasion of GBM.
BK Channel Properties and Modulators
BK channels, encoded by the KCNMA1 gene and expressed
in virtually all tissues, are regulated by both [Ca2+]i and
membrane potential. They have the typical tetrameric structure
of K channels, with four α-subunits each displaying seven
transmembrane segments, with a unique S0 segment, and the
charged S4 segment conferring the voltage-dependence. Ca2+
sensitivity comes instead from the bulky C-terminal tail that
includes a negatively charged, high-affinity Ca2+ binding region
(the Ca2+ bowl; Schreiber and Salkoff, 1997; Jiang et al.,
2001), and the double negative charged RCK-domain (regulatory
domain for K conductance). Notably, in 2002 Sontheimer’s lab
identified a splice variant of the BK channel on a human glioma
cell line (D54), which they named gBK (g for glioma), being
highly expressed in GBM cells but not in normal tissue (Liu
et al., 2002). This variant has a significantly higher sensitivity to
[Ca2+]i than normal BK channels, and can be activated by agents
that raise the [Ca2+]i to several hundred nanomolar (Ransom
et al., 2002), concentrations relatively high, yet observed in the
presence of extracellular Ca2+ agonists.
Here we will recall the principal features of the BK channel
modulators that will be encountered below, namely the BK
channel blockers tetraethylammonium (TEA), iberiotoxin (IbTx)
and paxilline, and the BK channel openers NS1619 and phloretin.
TEA is a rather unspecific K channel blocker. However, among
the TEA-sensitive K channels, the BK channel results one of
the most sensitive to TEA (IC50 below 1 mM). For this reason,
concentrations of TEA of a few millimolar may be considered a
pharmacological tool to selectively inhibit BK channels in GBM
cells, where other TEA-sensitive K channels are not expressed.
IbTx is a 37 aminoacid peptide purified from the scorpion Buthus
tamulus, that selectively blocks the BK channel at nanomolar
concentrations from the external side, by driving the channel
into a closed state that can last minutes. Paxilline is a fungal
alkaloid that potently inhibits BK channels in a state-dependent
manner, as it binds more tightly to the closed state. Binding
appears to occur at a superficial location near the external
vestibule, but does not prevent access of smaller molecules to
this cavity (Zhou and Lingle, 2014). Unfortunately, paxilline
has also been shown to inhibit the endoplasmic reticulum Ca-
ATPase (SERCA; IC50 of 5–50 µM depending on the specific
type of the transporter; Bilmen et al., 2002) and to sensitize
the TRAIL (TNF-related apoptosis-inducing ligand)-induced
GBM cell death, an effect mimed by other SERCA inhibitors,
but not by other BK channel inhibitors (Kang et al., 2011).
These results suggest caution when drawing conclusions on the
role of BK channels using paxilline as the only BK channel
inhibitor. NS1619 is a potent benzimidazolone BK channel
opener (EC50 10–30 µM; Olesen et al., 1994). It has been recently
shown in C2C12 and H9C2 cells that NS1619 releases Ca2+
from internal stores and prevents Ca2+ accumulation by the
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SR vesicles (Wrzosek, 2014). In addition, NS1619 effectively
inhibits IK channels also expressed in GBM cells (Warth et al.,
1999; our unpublished observation in GBM cells), suggesting
caution when interpreting data on the functional effects of this
compound.
Literature Survey on BK Channels and
GBM Cell Migration
To verify whether cell shrinkage determined by K+ and Cl− ion
efflux is a requirement for tumor cells invasion through narrow
extracellular spaces in the brain, Soroceanu et al. (1999) tested
the effects of a number of Cl and K channel blockers on GBM
cells migration, using different migration assays. They found
both IbTx and TEA (1 mM) to effectively inhibit GBM transwell
migration through 8-µm pores coated with the ECM component
vitronectin. TEA was also able to inhibit GBM cell invasion
through both cellular aggregates of fetal rat brain and normal
brain slices, but did not modify 2D GBM cell migration tested
on culture dishes by time lapse video-microscopy. These results
led the authors to postulate that BK channels give an important
contribution only when GBM cell migration occurs through
the narrow extracellular spaces that characterize the brain
parenchyma, where volume and shape changes are especially
needed.
Another study prompted by the observation that patients
with brain tumors often have high levels of acetylcholine (ACh)
in their cerebrospinal fluid showed that raising the [Ca2+]i by
muscarinic activation of ACh receptors activated BK channels
and inhibited U373 cell migration tested with a 2Dmotility assay
(Bordey et al., 2000). These results were confirmed few years later
on another GBM cell line by Kraft et al. (2003), who also found
that activation of BK channels with NS1619 and phloretin had
similar inhibitory effects on 2D motility. They found however
that the BK channel activator phloretin also increased the resting
[Ca2+]i (from 235–470 nM). Notably, the effects of phloretin and
ACh on cell migration were abolished by co-application of the
specific BK channel blockers paxilline and IbTx, while the same
blockers had no effects on the basal cell migration (i.e., migration
in the absence of BK channel activators). These findings indicate
that BK channel activation by increased [Ca2+]i or selective
agonists results in inhibition of GBM cell migration.
Based on the notion that 2D migration assays, as used in the
previous studies, do not exactly mimic the type of migration
taking place when GBM cells infiltrate through the brain
parenchyma in vivo, Sontheimer and coworkers reexamined the
effects of BK channel inhibitors and activators on GBM cell
migration using the transwell migration assay with 8 µm pores,
a size small enough for typical GBM cells to pass through only
upon significant shrinking (Weaver et al., 2006). Under these
conditions they found that inhibition of BK channels with either
IbTx or paxilline markedly reduced migration of GBM cells.
These results, essentially in conflict with the previous studies,
seemed to give credit to the notion that different migration
modes are regulated in different ways by BK channels. Namely,
when migration requires significant cell volume changes, such
as those needed to pass through narrow pores, BK channels are
important since they concur significantly to sustaining the K+
efflux required for cell shrinkage.
Another investigation addressed the role of BK channels on
migration of GBM cells usingmenthol, an agonist of the transient
receptor potential melastatin 8 (TRPM8) channel, to increase
[Ca2+]i (Wondergem and Bartley, 2009). Menthol was found to
activate BK channels, and to increase the rate of DBTRG cell
migration, an effect that was inhibited by paxilline and TEA.
The same inhibitors were instead ineffective when tested on
basal migration (i.e., in the absence of menthol). These results,
obtained with a 2D migration assay (scratch wound), were at
odds with the data previously reported, and seemed to rule out
the interpretation that the involvement of BK channels in GBM
cell migration depends on the migration type. Notably, this study
also found that inhibition of BK channels not only restrained
menthol-induced cell migration, but also thementhol-stimulated
[Ca2+]i increase, suggesting that BK channels also help raise
[Ca2+]i, which they do by hyperpolarizing the cell and increasing
the electrochemical potential for Ca2+ influx.
Based on previous observations showing that migration of
GBM cells is stimulated by ionizing radiation (IR), Steinle
et al. (2011) tested whether IR-induced GBM cell migration
involved BK channels. Their study showed that IR activated
BK channels and enhanced transwell migration in a paxilline-
dependent manner in T98G and U87MG cells. They further
observed that IR also activated the Ca2+/calmodulin-dependent
kinase II (CaMKII), and that its inhibition by KN-93 abolished
the IR-stimulated migration. Based on these data, these authors
concluded that IR stimulates BK channel activity which results in
activation of CaMKII leading to enhanced cell migration.
Reconciling Data on the Involvement of BK
Channels in GBM Cell Migration
In the previous section we have reviewed the available data on the
contribution of BK channels to GBM cell migration, and found
a highly diversified outcome oscillating from a negative to null,
to positive action. In the following, we will try to work out a
paradigm capable of reconciling the presently available data on
BK channel involvement in GBM cell migration into a unifying
model (Figure 1). In this undertaking we consider as primary
players the cell Ca2+ signaling and the migration mode.
2D cell migration in the absence of Ca2+ and BK channel
agonists—If we restrict the analysis of the experimental data to
those obtained in 2D migration assays in the absence of Ca2+
or BK channels agonists, the results obtained by the various
groups become essentially coherent. Monitoring single U251
cell migration by 2D time-lapse video-microscopy, Soroceanu
et al. (1999) found that 1 mM TEA was ineffective on 2D
cell migration. Kraft et al. (2003), using the same technique,
reported that 100 nM IbTx and 2µMpaxilline were ineffective in
inhibiting basal migration of 1321N1 cells. Likewise,Wondergem
and Bartley (2009) reported that 10 mM TEA and 2 µM
paxilline were ineffective on the wound healing 2D assay
performed on DBTRG cells. All these data indicate that BK
channels do not contribute to the basal 2D migration, consistent
with the finding that at the resting [Ca2+]i (100–200 nM;
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FIGURE 1 | Sketch illustrating the proposed unifying view to
reconcile present data on the involvement of BK channels in
glioblastoma (GBM) cell migration. The Figure reports in separate
panels the impact of three distinct experimental conditions on BK
channel activity and cell migration, namely, absence of BK channel or
Ca2+ agonists (first panel), and presence of two different Ca2+ agonists
(ACh and menthol) that raise [Ca2+]i to markedly different values (second
and third panels). Each panel reports, from top down, a sketch of the
major elements involved, as ion channels, membrane receptors, signaling
pathways, [Ca2+]i , BK channel agonists and inhibitors. Lower level shows
reconstructed BK single channel current traces indicating the level of
channel activity under the various conditions. The bottom part illustrates
the BK channel activity as qualitatively derived from BK single channel
data above, and the corresponding GBM cell migration rate. First panel
shows that BK channel antagonists are ineffective in inhibiting basal
migration. This possibly indicates that under these conditions BK
channels do not contribute sensibly to basal migration, consistent with
the finding that at the resting [Ca2+]i (100–200 nM) and membrane
potential of GBM cells (30–50 mV negative) the BK channel activity is
close to zero. Second panel shows that ACh inhibits cell migration, and
the effect is reversed by IbTx. ACh has been reported to increase
[Ca2+]i to a level well above 750 nM, a value capable to activate the
BK channels of resting cells. These data thus suggest that a high and
steady activation of BK channels exerts a negative effect on migration,
possibly because this high and steady K+ efflux does not tune with the
cyclic cell volume changes needed for cell migration. In this context it is
relevant to notice that menthol (third panel), that activates the transient
receptor potential melastatin 8 (TRPM8) channel and increases resting
[Ca2+]i only to ca. 300 nM, a value too low to activate BK channels of
a resting cell, promotes 2D cell migration. However, if we consider the
additional increments of [Ca2+]i due to serum-induced [Ca2+]i oscillations,
BK channels would be cyclically activated during menthol exposure at
the oscillatory peaks, and in this way serve nicely the cyclical K+ efflux
needed for cell migration.
Bordey et al., 2000; Kraft et al., 2003) and membrane potential
of GBM cells (−50 to −20 mV; Ransom et al., 2002; Fioretti
et al., 2009), the BK channel activity is close to zero (see
Ramson et al., 2002 for GBM BK channel activity at varying
[Ca2+]i and membrane potentials). Not even serum, present
in all the migration assays referred to above, and shown to
promote [Ca2+]i oscillations in U87MG cells (Rondé et al., 2000;
Giannone et al., 2002), was able to activate BK channels at any
significant level under these experimental conditions, as expected
from previous studies (Catacuzzeno et al., 2011, 2012b). The
absence of a role of BK channels in basal 2D migration may thus
be the result of their inactivity at the [Ca2+]i and membrane
potentials typical of GBM cells in a culture dish (Figure 1, left
panel).
2D cell migration in the presence of Ca2+ and BK channel
agonists—Kraft et al. (2003) reported that phloretin and ACh
inhibited 2D cell migration, and the effect was reverted by
IbTx (100 nM) and paxilline (2 µM). They also showed that
phloretin, besides directly activating the BK channel, increased
the [Ca2+]i to values close to 500 nM, and these two effects
combined brought to BK channel activation at the resting
potential of GBM cells. Bordey et al. (2000) similarly found
that ACh, acting on muscarinic receptors, increased the [Ca2+]i
to a level well above 800 nM, a value capable to activate the
BK channels of resting cells (Ransom et al., 2002). These data
suggest that a marked and steady activation of BK channels,
attained either by increasing the [Ca2+]i or using BK channel
activators, exerts a negative control on 2D migration, possibly
because this constant K+ efflux does not tune with the cyclic
cell volume changes needed during migration (Figure 1, center
panel). In this context, Wondergem and Bartley (2009) reported
that menthol, unlike ACh and phloretin, promotes 2D cell
migration tested by wound-healing assay, an effect that was
reverted by paxilline and TEA. Interestingly, menthol increased
the resting [Ca2+]i only to about 300 nM, a value much lower
than that induced by ACh and phloretin, and too low to activate
BK channels in a resting cell. However, if we consider the
additional increments of [Ca2+]i due to serum-induced [Ca2+]i
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oscillations (Catacuzzeno et al., 2011), BK channels would be
cyclically activated at the oscillatory peaks, and in this way allow
the cyclical activity needed for cell migration (Figure 1, right
panel).
3D cell migration—Soroceanu et al. (1999) reported that 10
nM IbTx and 1 mM TEA inhibited the 3D transwell migration
of U251 GBM cells by 20% and 50%, respectively. In accordance
Weaver et al. (2006) reported that 100 nM IbTx and 2 µM
paxilline inhibited the 3D transwell migration by 60% and 80%,
respectively. These data indicate that, in contrast to what has
been observed in 2D cell migration assays, in 3D migration BK
channels have a prominent role also under basal, unstimulated
conditions, i.e., in the absence of Ca2+ or BK channel agonists.
This implies that in 3D transwell migration assays, BK channels
have a significant activity even in the absence of extracellular
agonists, possibly due to an elevated resting [Ca2+]i level.
Interestingly, in the 3D transwell migration assays reported
above the pore filters were routinely coated with vitronectin, an
ECM component secreted by GBM cells, that has been shown to
increase [Ca2+]i through its interaction with plasma-membrane
integrins (Schwartz, 1993; Shankar et al., 1995).
Conclusions
Based on the above data, the involvement of BK channels
in GBM cell migration, more than on the cell migration
mode (2D vs. 3D), appears to primarily depend on the
features of the Ca2+ signals (i.e., steady vs. oscillatory),
and ultimately on the degree and mode (again, steady vs.
oscillatory) of BK channel activation. More specifically, for
[Ca2+]i too low for BK channels to be activated, they
will not obviously be able to contribute to cell migration.
By contrast, an intermediate [Ca2+]i, as that induced by
menthol, although insufficient to activate BK channels, is
decisive as it predisposes the background for BK channels
cyclic activation following oscillatory [Ca2+]i increases, such
as those induced by serum or other Ca2+ agonists. This
type of cyclic BK channels activity represents an important
contribution to cell migration, possibly by underlying the cyclic
cell volume changes needed during migration. Finally, very high
[Ca2+]i, such as those generated by ACh and phloretin, that
keep BK channels steadily (continuously) active will disfavor
cell migration because a steady K+ efflux is unsuitable to
match the cyclic cell volume changes needed for proper cell
migration.
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